Top Markets
Coin of the day
Gwo Xi Stem Cell Applied Technology Co. , Ltd Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704
Rang in Aktien #24642
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem... Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
Aktienkurs
$0.60736143
Marktkapitalisierung
$58.28M
Veränderung (1 Tag)
-1.04%
Veränderung (1 Jahr)
-21.09%
Land
TW
Handel Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)

Kategorie

Kursverlauf für Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)
Höchster Schlusskurs: $0.61 am 2026-08-01

Niedrigster Schlusskurs: $1.47 am 2023-04-01
Kursverlauf der Aktie von Gwo Xi Stem Cell Applied Technology Co. , Ltd von 2023 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -11.38%
2025 1.08%
2024 -27.87%
2023 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$550.26 38.44%
US
$1.05K 58.16%
NL
$148.90 467.89%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH